论文部分内容阅读
目的：对比多索茶碱与氨茶碱治疗支气管哮喘的临床疗效。方法：以我院收治的44例支气管哮喘患者作为研究对象，将其随机分为多索茶碱组、氨茶碱组各22例。两组于常规治疗基础上分别接受多索茶碱与氨茶碱静脉滴注，对比两组治疗一周后的临床疗效。结果：多索茶碱组有效率％，高于氨茶碱组的％，组间差异具有统计学意义（P＜0．05）；多索茶碱组肺功能改善优于氨茶碱组，且临床不良反应发生率低于氨茶碱组，组间具有统计学意义（P＜0．05）。结论：多索茶碱治疗支气管哮喘优于氨茶碱，患者肺功能改善较优，临床不良反应少，值得推广使用。“,”objective:to compare the doxofyl ine and aminophyl ine in the treatment of bronchial asthma clinical ef icacy.Methods:44 cases of bronchial asthma patients in our hospital as the research object,which were randomly divided into doxofyl ine and aminophyl ine group al 22 cases.Two groups based on the conventional treatment respectively accept doxofyl ine and aminophyl ine intravenous drip,and compared the clinical ef icacy of the two groups after treatment for a week.Results:doxofyl ine group ef icient %,% higher than that of aminophyl ine group,diference between groups with statistical significance (P <0.05);Doxofyl ine improve lung function is bet er than that of aminophyl ine group,and lower incidence of clinical adverse reactions than aminophyl ine group,between groups with statistical significance (P <0.05).Conclusion:doxofyl ine the treatment of bronchial asthma is bet er than that of aminophyl ine,rela-tively optimal improve lung function,less clinical adverse reactions,worthy of promotion of use.